Recent Headlines
Two New Lamin A + C Antibodies Announced by Novus Biologicals
Novus Biologicals announced today two new Lamin A+C antibodies for use in epigenetic research and for certain cancer research. Lamins and lamin-associated proteins help shape the nucleus and provide a scaffold-type support system for chromosomes and replicating DNA to interact with epigenetic... - October 06, 2011 - Novus Biologicals
FyMed Reinforces Its Drug Development Pipeline with Novel Strategies in Personalized Medicine
FyMed, Inc., a biopharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries, recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in personalized medicine. - October 06, 2011 - FyMed Inc
Novus Biologicals Announces New LAMP2 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new LAMP2 antibody (catalog number NBP1-71692) for use as a cell marker in autophagy signaling and cancer research. This LAMP2 antibody was developed using SDIX Genomic Antibody TechnologyTM. LAMP2 is a member of a family of membrane glycoproteins. Specifically,... - October 05, 2011 - Novus Biologicals
New Group of EpiPlus Histone Modification Antibodies Released
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - September 30, 2011 - Novus Biologicals
AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide
AnaSpec is pleased to support advances in MS research by providing MOG (35 - 55), mouse, rat, a key peptide that induces severe chronic experimental autoimmune encephalomyelitis in transgenic mice. - September 29, 2011 - AnaSpec, EGT Group
AnaSpec Offers Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research. This includes MOG proteins, peptides, antibodies and assay kits. Myelin Oligodendrocyte Glycoprotein (MOG), a protein with a molecular weight of 26- to 28-kDa,... - September 29, 2011 - AnaSpec, EGT Group
New Argentine Distributor Announced by Novus Biologicals
Novus Biologicals announced today a new distributor partnership in Argentina with Migliore Laclaustra, S.R.L. Argentina is a biotechnology leader in Latin America, with more than 80 multinational corporations and local companies currently operating nationally. The combination of a highly qualified... - September 29, 2011 - Novus Biologicals
Launch of Biotechnology Portal cellexis.com – Marketing of Innovative Cell Culture Technology
atech system solutions Ltd. (“atech”) has launched the online service www.cellexis.com for marketing and distribution of innovative products and services in the field of cell culture technology. The online service www.cellexis.com is the portal for distribution of bioreactor systems that are marketed under the name “cellexis one” and services like the delivery of manufacturing processes for cell culture products according to international standards. - September 22, 2011 - atech system solutions Ltd.
New Histone H3 [dimethyl Lys9/phospho Thr6] Antibody Released
Today, Novus added a new Histone H3 [dimethyl Lys9/phospho Thr6] antibody to their growing line of EpiPlusTM histone modification antibodies. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate... - September 21, 2011 - Novus Biologicals
atech system solutions Develops New Bioreactor Platform for Cell Culture-Based Manufacturing
The atech system solutions Ltd. presents a new generation of bioreactor systems for cell culture-based manufacturing of biopharmaceutical compounds. The new development comprises a platform technology with high performance, safety as well as environmental compatibility and simplification of cell culture-based manufacturing methods. The system platform will be marketed under the brand name “cellexis one.” - September 17, 2011 - atech system solutions Ltd.
Novus Biologicals Announces New NODAL Antibody Made Using SDIX Genomic Antibodiy Technology™
Novus Biologicals announced today a new NODAL antibody (catalog number NBP1-71686) for the study of cancer, angiogenesis and stem cells. This NODAL antibody was made using SDIX Genomic AntibodiesTM (GATTM). This NODAL Antibody (NBP1-71686) serves as an excellent tool for studying stem cell... - September 11, 2011 - Novus Biologicals
AnaSpec Introduces Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide Anti-MOG (Myelin Oligodendrocyte Glycoprotein) ELISA assay kits. The SensoLyte® Anti-Human MOG (1-125) IgG Quantitation ELISA Kit, SensoLyte® Anti-Mouse MOG (1-125) and SensoLyte® Anti-Rat MOG (1-125) IgG ELISA assay kits are... - September 10, 2011 - AnaSpec, EGT Group
AnaSpec Provides Industry’s Largest Collection of Anti-Tau Antibodies
In Alzheimer’s disease (AD), the major pathological hallmarks are β-sheet aggregates of β-amyloid peptides in senile plaques and hyperphosphorylated tau protein in neurofibrillary tangles (NFT).1-2 AnaSpec, a provider of one of the world’s largest collections of β-amyloid... - September 10, 2011 - AnaSpec, EGT Group
Synpromics Teams with Scottish Enterprise to Accelerate Growth
Synpromics Ltd announces the formal support of Scottish Enterprise’s High Growth Start-Up Unit (HGSU). Synpromics intends to leverage this valuable affiliation to help drive growth as the company transitions from a start-up business to an established globally-focused corporation in the future. - August 31, 2011 - Synpromics Ltd
AnaSpec Offers ClearPoint™ β-Amyloid Custom Peptide Synthesis Service
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents, also provides ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled... - August 24, 2011 - AnaSpec, EGT Group
AnaSpec Offers SensoLyte® 520 TACE Assay Kit
While fluorimetric assay kits for the detection and inhibitor screening of Tumor Necrosis Factor alpha (TNF-α) Converting Enzyme (TACE) currently exist, none of these have been able to take full advantage of the performance provided by long wavelength FRET technologies. AnaSpec’s... - August 24, 2011 - AnaSpec, EGT Group
Novus Releases New Mix-and-Match Pathway Assay Kits
Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a... - August 18, 2011 - Novus Biologicals
MoBiTec GmbH, Germany, is Offering Nuclear Receptor Fusion Proteins That Are of Importance to the Pharmaceutical Industry for FRET Interaction Studies
MoBiTec GmbH, Germany, supplier of research tools, introduces a collection of Nuclear Receptor-Ligand Binding Domain fusion proteins, carrying a GST tag, capable to bind a Europium-anti-GST antibody. With this the influence of fluorophore-labeled peptides on the ligand binding characteristics can be studied. E.g. the addition of a particular peptide might prevent the receptor from binding a ligand, thereby eliminating a response of a cell to a given stimulus. - August 17, 2011 - MoBiTec GmbH
Mouse Monoclonal DUX4 Antibody Announced by Novus Biologicals
DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD... - August 17, 2011 - Novus Biologicals
AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine
AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - August 14, 2011 - AnaSpec, EGT Group
AnaSpec Highlights Calcein AM with High Purity Grades
AnaSpec is pleased to provide Calcein AM at two purity grades, >90% or >95%, as determined by HPLC. AnaSpec also offers the SensoLyte® Calcein Cell Viability Assay Kit - a rapid and sensitive assay to detect viable cells. This kit provides ample reagents (dye and assay buffer) for 1000... - August 14, 2011 - AnaSpec, EGT Group
Mitegen Announces Distribution of AP Innovation's Quick Puck Loader
Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC
Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals
Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals
Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™
Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says
A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc
Valencia Practice Adpots New and Discreet STARR Weight-Loss Treatment
Town Center Surgery’s Dr. Monali Misra praises privacy and comfort of new procedure, no visible scars. - July 21, 2011 - TransEnterix
AnaSpec Releases Anti-LL-37
AnaSpec is pleased to announce the release of a new anti-LL-37. Rabbit Anti-human Cathelicidin LL-37 polyclonal antibody was raised against a synthetic peptide from a sequence found within 134-170 amino acid residues (LL-37) of the LL-37 precursor human cationic antimicrobial protein, hCAP-18... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Expands SensoLyte® MMP Assay Kits Collection
Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Specializes in Custom Peptide Synthesis
Since 1993, AnaSpec has assisted scientists in the design and synthesis of >50,000 peptides. As a result, AnaSpec's combined knowledge and expertise provide premium solutions to its customers. AnaSpec routinely completes difficult peptide synthesis such as synthesis of long peptides... - July 15, 2011 - AnaSpec, EGT Group
2nd International Conference on Tocotrienols and Chronic Diseases at Wynn Resort, Las Vegas, July 2011
Latest research studies, technical application as well as market potential of palm tocotrienol complex will be shared in this conference. - July 08, 2011 - Carotech Inc.
New Virus Modification Approach to Creating Vaccines for Insect-Borne Diseases
A technology breakthrough that could have a major impact in the development of vaccines to preventive insect-borne diseases has been published in the June edition of Virology Journal, - July 07, 2011 - Arbovax Inc
Novus Biologicals Announces Opening of Canadian Office
Novus Biologicals, an international supplier of antibodies and antibody-related products to bioscience researchers, is proud to announce the opening of their second international office in Oakville, Ontario, Canada. Novus' other offices include Novus Europe, which services Europe from Cambridge,... - June 30, 2011 - Novus Biologicals
Mitegen Awarded $250K NIH STTR Phase II Grant
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a phase II STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of improved crystallization plates. - June 27, 2011 - MiTeGen, LLC
OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances
OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Offers Custom Assay Development Service
AnaSpec, EGT Group, provider of the long wavelength, ultra-sensitive SensoLyte® assay kits, is pleased to offer custom service for the development of assays. The long wavelength of SensoLyte® protease assays, many of which utilize the 5-FAM/QXL™ 520 and HiLyte Fluor™... - June 23, 2011 - AnaSpec, EGT Group
AnaSpec Highlights Anb-Wang Resin
Colorimetric based Peptide-p-Nitroanilide conjugates (peptide-pNAs), with absorbance at approximately 408 nm, have historically been and are still widely used substrates for the study of protease activity. However, the preparation of peptide-pNA presents technical challenges. The amino group of pNA... - June 23, 2011 - AnaSpec, EGT Group
One-Shot Dengue Fever Vaccine Moves Closer to Reality
Arbovax, Inc. is an early stage biotechnology company based in Raleigh NC, developing a novel and innovative technology to facilitate the development of vaccines against insect-borne viruses. Their initial focus, Dengue Fever, is ranked second only to Malaria by the World Health Organization for its devastating global impact. - June 21, 2011 - Arbovax Inc
MoBiTec Expands Its Selection of High Quality Gene Expression Systems for Bacillus megaterium
Based on its already successful protein expression systems for Bacillus megaterium, MoBiTec GmbH introduces a new family of protein expression vectors, the hp-Expression Systems, for high yield expression in the well-established organism Bacillus megaterium. This new system complements the existing non-E. coli expression systems for B. megaterium, Bacillus subtilis, Lactococcus lactis and yeast. Further non-E. coli expression systems are in preparation. - June 09, 2011 - MoBiTec GmbH
Aciont® to Present at the 13th Annual NIH SBIR/STTR Conference
Dr. Kongnara Papangkorn’s presentation is entitled, “Safety Aspects and Drug Delivery Performance of Visulex® Passive Delivery System” - June 09, 2011 - Aciont Inc.
Carotech to Showcase GRAS-Approved Tocomin Palm Tocotrienol Complex at IFT 2011, New Orleans, Louisiana, USA
Carotech will share applications and benefits of TocoBev tocotrienol beverage powder at IFT. - June 09, 2011 - Carotech Inc.
AnaSpec Introduces DPPIV Assay Kit
AnaSpec, EGT Group is pleased to introduce a new long wavelength fluorimetric assay kit for determining Dipeptidyl Peptidase IV (DPPIV) activity, the SensoLyte® Rh110 DPPIV Assay Kit. This kit contains a substrate that emits in the green range of 520 nm when cleaved by DPPIV. The kit provides a... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Offers High-Throughput Dispensing Service
AnaSpec, EGT Group is pleased to offer high-throughput dispensing service. Their commitment to supply the life science community with simple, affordable and innovative solutions has resulted in this service: bringing the advantages of automation within everyone’s reach. The fully equipped... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Introduces Anti- β-Amyloid
AnaSpec, Eurogentec Group is pleased to announce the release of two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42). These two antibodies are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA. - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Introduces Speedy 28-Day Custom Polyclonal Antibody Service
When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - May 27, 2011 - AnaSpec, EGT Group
Mitegen Announces Mutual Distribution Agreements with Omscientia
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual non-exclusive distribution agreements with Omscientia, a... - May 26, 2011 - MiTeGen, LLC
AnaSpec Highlights MMP Inhibitors
AnaSpec, Eurogentec Group, is pleased to release 11 MMP inhibitors to complement their wide offering of MMP SensoLyte® 520 and 490 fluorimetric kits, colorimetric kits, recombinant proteins, and Z-Fish™ antibodies (antibodies specific for zebrafish). These MMP inhibitors are small... - May 25, 2011 - AnaSpec, EGT Group
TransEnterix Receives Global Entrepreneurial TiE50 Award
For demonstrating ingenuity and innovation as a life-science startup company, TransEnterix has received the prestigious TiE50 Award for 2011. The TiE50 Awards are given each year by TiE, the organizer of TiEcon, the world’s largest annual conference for entrepreneurs. One of 10 winners in... - May 14, 2011 - TransEnterix
OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande
OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River. The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program). The P2... - May 13, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Mitegen Announces Mutual Distribution Agreements with NatX-ray
Improving customer access to industry leading products from both companies. - April 30, 2011 - MiTeGen, LLC